Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pall And FDA Will Discuss Studies To Support Prion Disease Filter Approval

This article was originally published in The Gray Sheet

Executive Summary

Pall Corp. plans to meet with FDA before the end of the year to discuss what studies will be necessary to approve its prion filtration system for blood transfusion processing, the firm says
Advertisement

Related Content

Abbott, ProMetic Pacts With Red Cross Cover Blood Screening, TSE Removal
Abbott, ProMetic Pacts With Red Cross Cover Blood Screening, TSE Removal
Advertisement
UsernamePublicRestriction

Register

MT022874

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel